1. Home
  2. ADP vs BMY Comparison

ADP vs BMY Comparison

Compare ADP & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Automatic Data Processing Inc.

ADP

Automatic Data Processing Inc.

HOLD

Current Price

$250.40

Market Cap

98.2B

Sector

Technology

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$62.23

Market Cap

113.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADP
BMY
Founded
1949
1887
Country
United States
United States
Employees
N/A
32500
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.2B
113.5B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ADP
BMY
Price
$250.40
$62.23
Analyst Decision
Hold
Buy
Analyst Count
14
15
Target Price
$275.57
$61.73
AVG Volume (30 Days)
2.2M
9.8M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
3.16%
4.38%
EPS Growth
9.67
N/A
EPS
8.49
N/A
Revenue
$20,560,900,000.00
N/A
Revenue This Year
$7.08
N/A
Revenue Next Year
$5.69
N/A
P/E Ratio
$28.61
$17.26
Revenue Growth
7.07
N/A
52 Week Low
$188.16
$42.52
52 Week High
$315.92
$62.89

Technical Indicators

Market Signals
Indicator
ADP
BMY
Relative Strength Index (RSI) 60.77 64.63
Support Level $249.50 $56.46
Resistance Level $265.75 $62.39
Average True Range (ATR) 5.99 1.46
MACD -0.51 0.39
Stochastic Oscillator 58.69 90.73

Price Performance

Historical Comparison
ADP
BMY

About ADP Automatic Data Processing Inc.

Automatic Data Processing, or ADP, is a global, cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including PEO offerings, enabling clients to reduce HR overhead. Its broad suite serves customers of all sizes across diverse sectors, and the firm holds large market shares in its core markets. As of fiscal 2025, ADP counts over 1.1 million clients and manages payroll for more than 42 million workers across 140 countries.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: